Chronic Coronary Artery Disease (Cad) (Ischemic Heart Disease) - Pipeline Review, H2 2015

Submitted by: Submitted by

Views: 11

Words: 984

Pages: 4

Category: Business and Industry

Date Submitted: 09/30/2015 05:56 AM

Report This Essay

Researchmoz added Most up-to-date research on "Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015" to its huge collection of research reports.

Global Markets Directs, Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2015, provides an overview of the Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease)s therapeutic pipeline.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=359924

This report provides comprehensive information on the therapeutic development for Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making...